Literature DB >> 20530255

Intracellular sequestration of the NKG2D ligand ULBP3 by human cytomegalovirus.

Neil J Bennett1, Omodele Ashiru, Fiona J E Morgan, Yin Pang, Georgina Okecha, Rob A Eagle, John Trowsdale, J G Patrick Sissons, Mark R Wills.   

Abstract

Human CMV (HCMV) encodes multiple genes that control NK cell activation and cytotoxicity. Some of these HCMV-encoded gene products modulate NK cell activity as ligands expressed at the cell surface that engage inhibitory NK cell receptors, whereas others prevent the infected cell from upregulating ligands that bind to activating NK cell receptors. A major activating NKR is the homodimeric NKG2D receptor, which has eight distinct natural ligands in humans. It was shown that HCMV is able to prevent the surface expression of five of these ligands (MIC A/B and ULBP1, 2, and 6). In this article, we show that the HCMV gene product UL142 can prevent cell surface expression of ULBP3 during infection. We further show that UL142 interacts with ULBP3 and mediates its intracellular retention in a compartment that colocalizes with markers of the cis-Golgi complex. In doing so, UL142 prevents ULBP3 trafficking to the surface and protects transfected cells from NK-mediated cytotoxicity. This is the first description of a viral gene able to mediate downregulation of ULBP3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20530255     DOI: 10.4049/jimmunol.1000789

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  The Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack.

Authors:  Vu Thuy Khanh Le-Trilling; Ofer Mandelboim; Liat Dassa; Einat Seidel; Esther Oiknine-Djian; Rachel Yamin; Dana G Wolf
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

2.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 3.  NKG2D Receptor and Its Ligands in Host Defense.

Authors:  Lewis L Lanier
Journal:  Cancer Immunol Res       Date:  2015-06       Impact factor: 11.151

4.  Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Authors:  Tessa M Campbell; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 5.  Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

Authors:  Hunter K Roark; Jennifer A Jenks; Sallie R Permar; Mark R Schleiss
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

6.  Endoplasmic Reticulum (ER) Reorganization and Intracellular Retention of CD58 Are Functionally Independent Properties of the Human Cytomegalovirus ER-Resident Glycoprotein UL148.

Authors:  Christopher C Nguyen; Anthony J Domma; Hongbo Zhang; Jeremy P Kamil
Journal:  J Virol       Date:  2020-02-14       Impact factor: 5.103

7.  Reevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.

Authors:  Daniel Malouli; Ernesto S Nakayasu; Kasinath Viswanathan; David G Camp; W L William Chang; Peter A Barry; Richard D Smith; Klaus Früh
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

Review 8.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  A CMV vaccine: TREATing despite the TRICKs.

Authors:  Chris A Benedict
Journal:  Expert Rev Vaccines       Date:  2013-10-04       Impact factor: 5.217

Review 10.  Immunogenetics of the NKG2D ligand gene family.

Authors:  Masanori Kasahara; Shigeru Yoshida
Journal:  Immunogenetics       Date:  2012-07-29       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.